Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...

Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of ...

Hims & Hers Health will shut down Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to “simplify its (company’s) dermatology ...

Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on ...

Hims & Hers Health ( NYSE: HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A ...

Hims and Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

Shares of Hims & Hers (HIMS) - which sells drugs like Cialis and anti-anxiety medications - tumbled 18% after hours. The decline over the past two trading days came after the Food and Drug ...

Bloomberg / Contributor / Getty Images Shares of Hims & Hers Health (HIMS) plunged in late trading Monday after the company reported falling margins as costs rose, overshadowing better-than ...

Hims & Hers Health said fourth-quarter revenue surged as demand for its weight-loss treatments took off throughout the year amid a competitor supply shortage. The telehealth-consultation platform ...

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading. Revenue increased 95% from a year earlier to $481 million ...